BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37431188)

  • 21. Single-subject classification of presymptomatic frontotemporal dementia mutation carriers using multimodal MRI.
    Feis RA; Bouts MJRJ; Panman JL; Jiskoot LC; Dopper EGP; Schouten TM; de Vos F; van der Grond J; van Swieten JC; Rombouts SARB
    Neuroimage Clin; 2018; 20():188-196. PubMed ID: 30094168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vivo
    Zhou XY; Lu JY; Liu FT; Wu P; Zhao J; Ju ZZ; Tang YL; Shi QY; Lin HM; Wu JJ; Yen TC; Zuo CT; Sun YM; Wang J
    Mov Disord; 2022 Mar; 37(3):525-534. PubMed ID: 34842301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modelling the cascade of biomarker changes in
    Panman JL; Venkatraghavan V; van der Ende EL; Steketee RME; Jiskoot LC; Poos JM; Dopper EGP; Meeter LHH; Donker Kaat L; Rombouts SARB; Vernooij MW; Kievit AJA; Premi E; Cosseddu M; Bonomi E; Olives J; Rohrer JD; Sánchez-Valle R; Borroni B; Bron EE; Van Swieten JC; Papma JM; Klein S;
    J Neurol Neurosurg Psychiatry; 2021 May; 92(5):494-501. PubMed ID: 33452053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.
    Rohrer JD; Nicholas JM; Cash DM; van Swieten J; Dopper E; Jiskoot L; van Minkelen R; Rombouts SA; Cardoso MJ; Clegg S; Espak M; Mead S; Thomas DL; De Vita E; Masellis M; Black SE; Freedman M; Keren R; MacIntosh BJ; Rogaeva E; Tang-Wai D; Tartaglia MC; Laforce R; Tagliavini F; Tiraboschi P; Redaelli V; Prioni S; Grisoli M; Borroni B; Padovani A; Galimberti D; Scarpini E; Arighi A; Fumagalli G; Rowe JB; Coyle-Gilchrist I; Graff C; Fallström M; Jelic V; Ståhlbom AK; Andersson C; Thonberg H; Lilius L; Frisoni GB; Pievani M; Bocchetta M; Benussi L; Ghidoni R; Finger E; Sorbi S; Nacmias B; Lombardi G; Polito C; Warren JD; Ourselin S; Fox NC; Rossor MN; Binetti G
    Lancet Neurol; 2015 Mar; 14(3):253-62. PubMed ID: 25662776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers.
    Lee SE; Sias AC; Kosik EL; Flagan TM; Deng J; Chu SA; Brown JA; Vidovszky AA; Ramos EM; Gorno-Tempini ML; Karydas AM; Coppola G; Geschwind DH; Rademakers R; Boeve BF; Boxer AL; Rosen HJ; Miller BL; Seeley WW
    Neuroimage Clin; 2019; 22():101751. PubMed ID: 30921613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.
    Fumagalli GG; Basilico P; Arighi A; Bocchetta M; Dick KM; Cash DM; Harding S; Mercurio M; Fenoglio C; Pietroboni AM; Ghezzi L; van Swieten J; Borroni B; de Mendonça A; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; Sorbi S; Scarpini E; Rohrer JD; Galimberti D;
    Alzheimers Res Ther; 2018 May; 10(1):46. PubMed ID: 29793546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers.
    Chen Q; Boeve BF; Schwarz CG; Reid R; Tosakulwong N; Lesnick TG; Bove J; Brannelly P; Brushaber D; Coppola G; Dheel C; Dickerson BC; Dickinson S; Faber K; Fields J; Fong J; Foroud T; Forsberg L; Gavrilova RH; Gearhart D; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford NR; Grossman M; Haley D; Heuer HW; Hsiung GR; Huey E; Irwin DJ; Jack CR; Jones DT; Jones L; Karydas AM; Knopman DS; Kornak J; Kramer J; Kremers W; Kukull WA; Lapid M; Lucente D; Lungu C; Mackenzie IRA; Manoochehri M; McGinnis S; Miller BL; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin KP; Rascovsky K; Sengdy P; Shaw L; Syrjanen J; Tatton N; Taylor J; Toga AW; Trojanowski J; Weintraub S; Wong B; Boxer AL; Rosen H; Wszolek Z; Kantarci K;
    Neurobiol Aging; 2019 Nov; 83():54-62. PubMed ID: 31585367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint.
    Staffaroni AM; Bajorek L; Casaletto KB; Cobigo Y; Goh SM; Wolf A; Heuer HW; Elahi FM; Ljubenkov PA; Dever R; Kornak J; Appleby B; Bove J; Bordelon Y; Brannelly P; Brushaber D; Caso C; Coppola G; Dheel C; Dickerson BC; Dickinson S; Dominguez S; Domoto-Reilly K; Faber K; Ferrall J; Fields JA; Fishman A; Fong J; Foroud T; Forsberg LK; Gavrilova R; Gearhart D; Ghazanfari B; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford N; Grant I; Grossman M; Haley D; Hsiung GY; Huey ED; Irwin DJ; Jones DT; Jones L; Kantarci K; Karydas A; Kaufer DI; Kerwin DR; Knopman DS; Kraft R; Kremers WK; Kukull WA; Litvan I; Lucente D; Lungu C; Mackenzie IR; Maldonado M; Manoochehri M; McGinnis SM; McKinley E; Mendez MF; Miller BL; Multani N; Onyike C; Padmanabhan J; Pantelyat A; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin KP; Rascovsky K; Roberson ED; Rogalski E; Sengdy P; Shaw LM; Syrjanen J; Tartaglia MC; Tatton N; Taylor J; Toga A; Trojanowski JQ; Weintraub S; Wang P; Wong B; Wszolek Z; Boxer AL; Boeve BF; Kramer JH; Rosen HJ;
    Alzheimers Dement; 2020 Jan; 16(1):11-21. PubMed ID: 31914230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia.
    Whiteside DJ; Malpetti M; Jones PS; Ghosh BCP; Coyle-Gilchrist I; van Swieten JC; Seelaar H; Jiskoot L; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Synofzik M; Galimberti D; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Butler CR; Santana I; Ber IL; Gerhard A; Ducharme S; Levin J; Danek A; Otto M; Sorbi S; Pasquier F; Bouzigues A; Russell LL; Rohrer JD; Rowe JB; Rittman T;
    Alzheimers Dement; 2023 May; 19(5):1947-1962. PubMed ID: 36377606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
    Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
    Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers.
    Clarke MTM; St-Onge F; Beauregard JM; Bocchetta M; Todd E; Cash DM; Rohrer JD; Laforce R
    Alzheimers Res Ther; 2021 Feb; 13(1):42. PubMed ID: 33568215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional brain connectivity in presymptomatic familial frontotemporal dementia.
    Dopper EG; Rombouts SA; Jiskoot LC; Heijer Td; de Graaf JR; Koning Id; Hammerschlag AR; Seelaar H; Seeley WW; Veer IM; van Buchem MA; Rizzu P; van Swieten JC
    Neurology; 2013 Feb; 80(9):814-23. PubMed ID: 23390180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.
    Domínguez-Vivero C; Wu L; Lee S; Manoochehri M; Cines S; Brickman AM; Rizvi B; Chesebro A; Gazes Y; Fallon E; Lynch T; Heidebrink JL; Paulson H; Goldman JS; Huey E; Cosentino S
    J Alzheimers Dis; 2020; 75(2):595-606. PubMed ID: 32310161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.
    van der Ende EL; Heller C; Sogorb-Esteve A; Swift IJ; McFall D; Peakman G; Bouzigues A; Poos JM; Jiskoot LC; Panman JL; Papma JM; Meeter LH; Dopper EGP; Bocchetta M; Todd E; Cash D; Graff C; Synofzik M; Moreno F; Finger E; Sanchez-Valle R; Vandenberghe R; Laforce R; Masellis M; Tartaglia MC; Rowe JB; Butler C; Ducharme S; Gerhard A; Danek A; Levin J; Pijnenburg YAL; Otto M; Borroni B; Tagliavini F; de Mendonça A; Santana I; Galimberti D; Sorbi S; Zetterberg H; Huang E; van Swieten JC; Rohrer JD; Seelaar H;
    J Neuroinflammation; 2022 Sep; 19(1):217. PubMed ID: 36064709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presymptomatic cognitive decline in familial frontotemporal dementia: A longitudinal study.
    Jiskoot LC; Dopper EG; Heijer Td; Timman R; van Minkelen R; van Swieten JC; Papma JM
    Neurology; 2016 Jul; 87(4):384-91. PubMed ID: 27358337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.
    Cash DM; Bocchetta M; Thomas DL; Dick KM; van Swieten JC; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; de Mendonça A; Sorbi S; Rossor MN; Ourselin S; Rohrer JD;
    Neurobiol Aging; 2018 Feb; 62():191-196. PubMed ID: 29172163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered Anterior Insular Metabolic Connectivity in Asymptomatic MAPT P301L Carriers.
    Chu M; Jiang D; Liu L; Nie B; Cui B; Wang Y; Rosa-Neto P; Wu L
    J Alzheimers Dis; 2023; 93(4):1369-1380. PubMed ID: 37182866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes.
    Malpetti M; Jones PS; Tsvetanov KA; Rittman T; van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Synofzik M; Galimberti D; Masellis M; Tartaglia MC; Finger E; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Otto M; Frisoni GB; Ghidoni R; Sorbi S; Heller C; Todd EG; Bocchetta M; Cash DM; Convery RS; Peakman G; Moore KM; Rohrer JD; Kievit RA; Rowe JB;
    Alzheimers Dement; 2021 Jun; 17(6):969-983. PubMed ID: 33316852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset.
    Wu L; Liu J; Feng X; Dong J; Qin W; Liu Y; Wang J; Lu J; Chen K; Wang Y; Jia J
    J Alzheimers Dis; 2018; 61(2):613-618. PubMed ID: 29226866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort.
    Bocchetta M; Todd EG; Bouzigues A; Cash DM; Nicholas JM; Convery RS; Russell LL; Thomas DL; Malone IB; Iglesias JE; van Swieten JC; Jiskoot LC; Seelaar H; Borroni B; Galimberti D; Sanchez-Valle R; Laforce R; Moreno F; Synofzik M; Graff C; Masellis M; Tartaglia MC; Rowe JB; Vandenberghe R; Finger E; Tagliavini F; de Mendonça A; Santana I; Butler CR; Ducharme S; Gerhard A; Danek A; Levin J; Otto M; Sorbi S; Le Ber I; Pasquier F; Rohrer JD;
    Brain Commun; 2023; 5(2):fcad061. PubMed ID: 36970046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.